Abstract

Concomitant deposition of amyloid -beta protein (Aβ) and neuronal tau as neurofibrillary tangles in the human brain is a hallmark of Alzheimer disease (AD). Because these deposits increase during normal aging, it has been proposed that aging brains may also undergo AD-like changes. To investigate the neuropathological changes that occur in the aging primate brain, we examined 21 brains of cynomolgus monkeys (7–36 years old) for Aβ- and tau-positive lesions. We found, 1) extensive deposition of Aβ in brains of cynomolgus monkeys over 25 years of age, 2) selective deposition of 4-repeat tau as pretangles in neurons, and as coiled body-like structures in oligodendroglia-like cells and astrocytes, 3) preferential distribution of tau in the basal ganglia and neocortex rather than the hippocampus, and 4) age-associated increases in 30–34 kDa AT8- and RD4-positive tau fragments in sarkosyl-insoluble fractions. We further labeled tau-positive structures using diaminobezidine enhanced with nickel, and visualized nickel-labeled structures by energy-dispersive X-ray (EDX) analysis of ultrathin sections. This allowed us to distinguish between nickel-labeled tau and background electron-dense structures, and we found that tau localized to 20–25 nm straight filaments in oligodendroglia-like cells and neurons. Our results indicate that the cytopathology and distribution of tau deposits in aged cynomolgus brains resemble those of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) rather than AD. Thus, even in the presence of Aβ, age-associated deposition of tau in non-human primates likely does not occur through AD-associated mechanisms.Electronic supplementary materialThe online version of this article (doi:10.1186/s40478-016-0385-5) contains supplementary material, which is available to authorized users.

Highlights

  • Animal models for Alzheimer disease (AD) have been developed mainly by using genetic modifications of rodents [1]

  • Because tau-positive deposits were abundant in the white matter (Fig. 1a, d, asterisks) and basal ganglia, (Fig. 1a, arrowhead) in the globus pallidus (GP, c), their distribution was different from that of AD in the human brain, which is prevalent in the hippocampus

  • Because Three repeat (3R) tau IR was absent in these AT8/RD4-positive lesions, their staining profile was different from that of human AD, which is immunopositive for both 3R and Four repeat (4R) tau [11, 12]

Read more

Summary

Introduction

Animal models for Alzheimer disease (AD) have been developed mainly by using genetic modifications of rodents [1] These models have not been able to provide a platform to develop diagnostic and therapeutic strategies that can be transferred to clinical practice. Tau-positive neurons in human AD brains usually exhibit immunoreactivity (IR) for both three repeat (3R) and four repeat (4R) tau in neurofibrillary tangles (NFTs) [8]. These AD-NFTs consist of tau in paired-helical filaments (PHFs), even in the early stages of the disease [9]. Tau lesions of PSP and CBD are often found in glia as tuft-shaped astrocytes, astrocytic plaques and coiled bodies, while neuronal tau is frequently found diffusely in the cytoplasm in a pretangle state [13]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.